Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilda J I de Jong

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis and Related Disorders|November 25, 2018
Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US womenHilda J I de Jong, Helen Tremlett, Feng Zhu, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
Metabolism: Clinical and Experimental|August 16, 2008
Alcohol consumption and blood lipids in elderly coronary patientsHilda J I de Jong, Janette de Goede, Linda M Oude Griep, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 24, 2023
[Prevalence and drug treatment of people with type 2 diabetes mellitus and a very high risk of cardiovascular disease]Erik H Serné, Jetty A Overbeek, Jan Palmen, et al.
BMJ Open|July 26, 2013
Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary careHilda J I de Jong, Joke C Korevaar, Liset van Dijk, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Antibiotic Utilization Among People With Multiple Sclerosis in the Netherlands, 2018-2020Melissa W Y Leung, Marloes T Bazelier, Bernard M J Uitdehaag, et al.
Pharmacoepidemiology and Drug Safety|June 8, 2012
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug usersHilda J I de Jong, Rob J Vandebriel, Siti R F Saldi, et al.
Annals of the Rheumatic Diseases|July 8, 2017
Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort studyHilda J I De Jong, Tjeerd P van Staa, Arief Lalmohamed, et al.
Plos One|February 24, 2018
Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalinkHilda J I de Jong, Jan Willem Cohen Tervaert, Arief Lalmohamed, et al.
Arthritis Research & Therapy|April 28, 2012
Statins accelerate the onset of collagen type II-induced arthritis in miceRob J Vandebriel, Hilda J I De Jong, Eric R Gremmer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|November 25, 2018
Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US womenHilda J I de Jong, Helen Tremlett, Feng Zhu, et al.
Eclinicalmedicine|November 12, 2019
Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019David M G Halpin, Hilda J I de Jong, Victoria Carter, et al.
Metabolism: Clinical and Experimental|August 16, 2008
Alcohol consumption and blood lipids in elderly coronary patientsHilda J I de Jong, Janette de Goede, Linda M Oude Griep, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 24, 2023
[Prevalence and drug treatment of people with type 2 diabetes mellitus and a very high risk of cardiovascular disease]Erik H Serné, Jetty A Overbeek, Jan Palmen, et al.
BMJ Open|July 26, 2013
Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary careHilda J I de Jong, Joke C Korevaar, Liset van Dijk, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Antibiotic Utilization Among People With Multiple Sclerosis in the Netherlands, 2018-2020Melissa W Y Leung, Marloes T Bazelier, Bernard M J Uitdehaag, et al.
Pharmacoepidemiology and Drug Safety|June 8, 2012
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug usersHilda J I de Jong, Rob J Vandebriel, Siti R F Saldi, et al.
Annals of the Rheumatic Diseases|July 8, 2017
Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort studyHilda J I De Jong, Tjeerd P van Staa, Arief Lalmohamed, et al.
Plos One|February 24, 2018
Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalinkHilda J I de Jong, Jan Willem Cohen Tervaert, Arief Lalmohamed, et al.
Arthritis Research & Therapy|April 28, 2012
Statins accelerate the onset of collagen type II-induced arthritis in miceRob J Vandebriel, Hilda J I De Jong, Eric R Gremmer, et al.
Pageof 2